PRESS RELEASE published on 05/15/2024 at 17:50, 2 years 3 months ago Informations privilégiées / Autres communiqués L'Assemblée Générale Mixte du 15 mai 2024 de la Société Arkema approuve largement les résolutions financières et reconduit M. Thierry Le Hénaff dans ses fonctions de Président-directeur général Performance Financière Assemblée Générale Mixte Résolutions Financières Société Arkema Thierry Le Hénaff
PRESS RELEASE published on 05/15/2024 at 17:50, 2 years 3 months ago Inside Information / Other news releases Arkema's shareholders approve resolutions at the combined annual general meeting chaired by Thierry Le Hénaff. Highlights include financial performance in 2023, strategic roadmap for 2028, and sustainability initiatives Annual General Meeting Financial Performance Strategic Roadmap Sustainability Initiatives ARKEMA
BRIEF published on 05/07/2024 at 15:24, 2 years 4 months ago Arkema Conducts Shares Buyback; Details and Prices Disclosed Share Buyback EU Regulation XPAR Market ARKEMA Chemicals Industry
BRIEF published on 05/07/2024 at 15:24, 2 years 4 months ago Arkema procède à un rachat d'actions ; Détails et prix divulgués Rachat D'actions Marché XPAR Industrie Chimique Règlement UE ARKEMA
PRESS RELEASE published on 05/07/2024 at 15:19, 2 years 4 months ago Inside Information / Other news releases Arkema discloses share buyback transactions undertaken from 29 April to 03 May 2024, in line with regulations. Visit their website for more details Transactions Share Buyback Investor Relations Regulation (EU) No 596/2014 ARKEMA
PRESS RELEASE published on 05/07/2024 at 15:19, 2 years 4 months ago Informations privilégiées / Autres communiqués Arkema annonce ses transactions sur actions propres du 29 avril au 03 mai 2024 conformément à la réglementation. Les détails sont disponibles sur leur site web Actions Propres Transactions Réglementation Rachats D'actions ARKEMA
BRIEF published on 04/30/2024 at 09:10, 2 years 4 months ago BlackRock Réduit Sa Participation dans ARKEMA Franchissement De Seuil BlackRock Marché Boursier Gestion D'actifs ARKEMA
BRIEF published on 04/30/2024 at 09:10, 2 years 4 months ago BlackRock Reduces Its Stake in ARKEMA Asset Management Stock Market BlackRock Crossing Threshold ARKEMA
PRESS RELEASE published on 04/30/2024 at 09:05, 2 years 4 months ago Franchissement de seuil Déclaration de franchissement de seuil de BlackRock Inc. pour 4,88% du capital d'ARKEMA. Détention de 3 660 111 actions Capital Franchissement De Seuil Actions BlackRock Inc. ARKEMA
BRIEF published on 04/30/2024 at 09:03, 2 years 4 months ago BlackRock dépasse les 5% du capital d'ARKEMA Investissement Franchissement De Seuil BlackRock ARKEMA Collatéral
Published on 09/11/2026 at 04:00, 5 hours 54 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 29 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 34 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 54 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 34 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 48 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 54 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 54 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 54 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 54 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 24 minutes ago Availability of the 2026 Interim Financial Report
